13-07-2026 23:00 via medpagetoday.com

Study Dampens Hope for GLP-1s as Insulin Off-Ramp in Type 2 Diabetes

(MedPage Today) -- Adding a GLP-1 receptor agonist was not associated with a lower likelihood of discontinuing existing basal insulin therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation trial...

Lifestyle Changes May Slow Brain Aging in Adults Younger Than 70

Aspirin Alone Gets the Job Done for Clot Prevention After Joint Surgery

Infants Not Given Vitamin K at Birth Had Greater Bleeding Risks, Including in Brain

Did His Unusual Dinner Lead to a Tape Worm 50 Years Later?

Aortic Dissection: What to Know About Lindsey Graham's Death

Declaring Death Is Not So Simple

Expanding Early Intensive Treatment Beyond Glycemia in Type 2 Diabetes

Later-Line Treatments for HER2-Positive Breast Cancer

Mitch McConnell Breaks Silence, Says Hospitalization Was Due to a Fall

U.S. Citizen Tests Positive for Ebola in Congo

Lindsey Graham's Cause of Death; Legionnaires' at the Guggenheim; Renowned Doc Dies

Alzheimer's Autopsy Study Raises Questions About Amyloid Clearance

'Do You Want the Toyota or the Lexus?': What We Heard This Week

Dementia Prevention Is Not One-Size-Fits-All, Study Shows

Desktop versie

Study Dampens Hope for GLP-1s as Insulin Off-Ramp in Type 2 Diabetes

Medical Industry news